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Circular dichroismGad-1 and Gad-2 are antimicrobial peptide (AMP) sequences encoded by paralogous genes. They are rich in his-
tidine, which suggests that their activity might be pH-dependent. We examined their structure–function rela-
tionships with a view to learning how to improve AMP therapeutic ratios. Activity assays with Gram-negative
bacteria and cancer cell lines demonstrate that Gad-2 is substantially more active at slightly acidic pH than it is
at neutral pH. By contrast, the activity of Gad-1 at lower pH is similar to its activity at pH 7. Circular dichroism
spectra indicate that the greater functional plasticity of Gad-2 correlates with a greater structural plasticity;
Gad-2's percent helicity varies dramaticallywith altered pH and lipid environment. Interestingly, Gad-2's highest
levels of helicity do not correspond to the conditions where it ismost active. High resolution solution NMR struc-
tureswere determined in SDSmicelles at pH 5, conditions that induce an intermediate level of helicity in the pep-
tides. Gad-1 is more helical than Gad-2, with both peptides exhibiting the greatest helical tendencies in their
central region and lowest helicity in their N-termini. The high resolution structures suggest thatmaximum activ-
ity relies on the appropriate balance between an N-terminal region with mixed hydrophobic/hydrophilic struc-
ture features and an amphipathic central and C-terminal region. Taken togetherwith previous studies, our results
suggest that to improve the therapeutic ratio of AMPs, consideration should be given to including sequential
histidine-pairs, keeping the overall charge of the peptide modest, and retaining a degree of structural plasticity
and imperfect amphipathicity.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) are a component ofmany organisms'
innate immune systems. They are one of the most ancient defense
mechanismswe have against pathogenic organisms such as bacteria, vi-
ruses and fungi, and some have also been observed to have anti-cancer
properties [1–3]. Because of their efﬁcacy they have survived the evolu-
tionary process even in organisms with highly complex immune sys-
tems. Many AMPs display speciﬁcity for pathogenic cells over host
cells, in large part due to differences in cell membrane composition.
AMP-membrane interactions are key in AMP mechanisms, either via
direct AMP killing by membrane disruption, or in order to gain entry
to the target cell to access intracellular targets [4]. Considering thewide-
spread decrease in the efﬁcacy of conventional antibiotics [5], thismembrane-speciﬁc property of AMPs makes them a highly attractive
alternative and therefore of great interest in the area of therapeutic
drugs. There has been success in developing and licensing AMP thera-
peutics for topical use [6], but, thus far, the development of injectable
AMP therapeutics has been hampered by the level of toxicity associated
with AMPs [7]. In other words, although many AMPs are more speciﬁc
for their target microbes than for the host cells, their therapeutic ratios
are still insufﬁciently high. Our studies of the AMPs Gad-1 andGad-2 are
thus designed with a view to better understanding the mechanisms for
their speciﬁcity and thus supporting the development of higher thera-
peutic ratio AMPs.
Gad-1 and Gad-2 are AMP sequences encoded by paralogous genes
previously identiﬁed from an Atlantic cod (Gadus morhua) expressed
sequence tag database [8]. Their importance to Atlantic cod innate im-
munity is supported by their high constituative transcript expression
in spleen, head kidney, gill, and blood and their up-regulation after
stimulation with bacterial antigens [8]. One interesting feature of the
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Gad-1 has ﬁve and Gad-2 has four. Histidine is noted for having a
pH-dependent charge and therefore the electrostatic interaction
with a charged membrane surface could depend on pH. Such histidine-
rich peptides are of interest in terms of understanding the physiological
control of AMP activity [9], in their potential for treating solid tumors,
which usually have an acidic environment [10,11], as well as in their
power to reveal the role of charge interactions in model studies by
allowing us to tune the charge of the AMP. Previously identiﬁed natural
histidine-rich AMPs include the human salivary peptide family of
histatins [12,13]; the root peptides shepherin I and shepherin II [14];
histidine-rich glycoprotein [15]; AMPs from ticks [16,17]; and clavanins
[18,19]. Other studies have focused on introducing non-native histidines
into peptides in place of Arg or Lys residues of native sequences or in-
corporating histidines into designed sequences [20–23]. Such studies
have suggested at least three different mechanisms for altered
histidine-rich-AMP activity with pH: 1) alterations in membrane
binding; 2) alterations in membrane penetration; and 3) alterations in
peptide structure.
In addition to alterations in activity with pH, also of interest are the
differences in activity between Gad-1 and Gad-2. Since they are
encoded by paralogous genes, we might expect their speciﬁcities to be
tuned to different pathogens. This possibility was investigated in anti-
microbial assays of four Gram-positive and eight Gram-negative bacte-
rial strains plus a protozoan, that employed peptides that were only
slightly different from those used in the current study; Gad-1 in the ear-
lier study had an additional C-terminal Gly and Gad-2 in the earlier
study lacked the C-terminal Arg [24]. The authors found that while the
Gad-1-like peptide was broadly active against bacteria, the Gad-2-like
peptide was not; the latter peptide exhibited higher activity against
the parasite [24]. The Gad peptides belong to a large family of related,
but diverse AMPs from ﬁsh, termed piscidins [25]. The most studied,
in terms of structural mechanisms, is a piscidin with 41% identity to
Gad-1 and 27% identity to Gad-2 [26]. It forms an amphipathic helix
that disrupts anionic bilayers [27], but to our knowledge alterations in
this behavior with pH have not been examined. Notably, this piscidin's
activity seems to depend on retaining conformational ﬂexibility [28].
Several studies point to conformational ﬂexibility as an important factor
in AMP speciﬁcity [29–31] and thus in our studies of Gad peptide struc-
ture–function mechanisms we need to keep in mind that the most
well-structured conformations of AMPs are not necessarily the most
biologically relevant conformations. While muchwork has been carried
out exploring the mechanisms of membrane disruption by AMPs,
including toroidal pore, carpet, and lipid clustering [32,33], at this
date, the particular mechanism(s) employed by Gad-1 and Gad-2 are
unknown.
A major reason for the paucity of clinical success with injected
AMP-based therapeutics is the level of toxicity associated with
AMPs [7]. Although many AMPs are more speciﬁc for their target mi-
crobes than for the host cells, their therapeutic ratios are still insufﬁ-
ciently high. The peptides Gad-1 and Gad-2 have potential to teach
us about how speciﬁcity is tuned in natural peptides and thus may
provide us with lessons we can apply to improve the therapeutic
ratio of other peptides in development for use in humans. The ﬁrst
consideration for speciﬁcity-tuning in Gads is their histidine resi-
dues, which introduce the possibility to alter charge interactions,
and hence activity, by changing the pH. Secondly, Gad-1 and Gad-2
are paralogous genes, and although they retain some sequence sim-
ilarity, they have also apparently evolved different speciﬁcities in
target microbes [24]. In order to better understand speciﬁcity-
tuning in the Gad peptides, we have assayed the pH dependence of
their anti-bacterial and anti-cancer activities, used circular dichro-
ism to learn how their helicity is altered with changes in pH or
lipid environment, and applied solution NMR to determine the high
resolution structures of the peptides in conditions that lead to an
intermediate level of helicity.2. Experimental methods
2.1. Peptide preparation
Putative mature Gad-1 (FIHHIIGWISHGVRAIHRAIH-NH2), and
Gad-2 (FLHHIVGLIHHGLSLFGDR-NH2) were produced by solid-
phase synthesis using O-ﬂuorenylmethyloxycarbonyl (Fmoc) chem-
istry. For each peptide, Fmoc amino acids were weighed out in 5×
excess and placed into a CS Bio peptide synthesizer (model CS336X,
CS Bio Company Inc., Menlo Park, CA) using 0.43 g of a 0.47 mmol/g
rink amide resin (CS Bio Company Inc., Menlo Park, CA). Dissolution
of amino acids was facilitated with 0.4 M 1-hydroxy-benzotriazole
(HoBt) dissolved in dimethylformamide (DMF). De-blocking of
amino acids was performed with 20% piperidine/DMF (Sigma-Aldrich
Co., St. Louis MO). Resin washes were carried out with DMF. Upon
completion of peptide synthesis, the resin containing peptide was
transferred to a 10 mL syringe (BD Diagnostics Co.) equipped with a
ﬁlter, and washed with methanol thoroughly under vacuum. The
resin was then air dried for 30 min followed by vacuum desiccation
for 60 min. Cleavage of the peptide from the resin was carried out
using a solution of 9.4 mL triﬂuoroacetic acid (TFA), 0.25 mL 1,2-
ethanedithiol, 0.1 mL thioanisole (Sigma-Aldrich Co.), and 0.25 mL
distilled water. The cleavage solution (5.0 mL) was added to the
resin and stirred for 2 h. The resulting solution, which contained the
C-terminally amidated peptide, was then extruded through the syringe
into a 50 mL Falcon tube (Fisher, Toronto ON). The peptide was then
precipitated with the addition of 40 mL of −20 °C diethyl ether, and
the tube was incubated at−20 °C overnight. The precipitate was then
pelleted by centrifugation at 4 °C at 2000 g for 5 min, the supernatant re-
moved, and two further ether precipitations were performed, each for
4 h. The resulting pellet was air-dried overnight, re-suspended in double
distilled water with 0.1% TFA (Sigma-Aldrich Co.), and ﬁltered using a
glass ﬁber Acrodisc syringe ﬁlter (Pall Canada Ltd., Ville St. Laurent, QC).
Peptide puriﬁcationwas performed using high-pressure liquid chro-
matography (HPLC) (Varian ProStar HPLC, Varian Inc., St. Laurent, QC)
equipped with a reverse-phase DYNAMAX C-8 preparatory column
(Varian Inc., St. Laurent, QC). Peptides were eluted at a wavelength
of 215 nm using an acetonitrile gradient (80/20% HPLC grade
water/acetonitrile — 0/100% acetonitrile; Sigma-Aldrich Co) with
monitoring at a wavelength of 215 nm and desalted by dialysis
against 5% acetic acid and then water. The mass of each peptide
was conﬁrmed via matrix assisted laser desorption ionization —
time of ﬂight mass spectrometry (MALDI-TOF MS — Genomics and
Proteomics facility, Memorial University). Final purity of the pep-
tides was determined to be N95% by analytical HPLC.
2.2. MIC assays
Minimal inhibitory Concentration (MIC) assays were carried out
using JM109 Escherichia coli. The working concentration of bacteria
was 5 × 105 cfu/mL inMueller Hinton (MH) broth. Two-fold serial dilu-
tions of peptides Gad-1 and Gad-2 were carried out in untreated sterile
96-well polypropylene plates where 10 μL of peptide was plated with
90 μL of bacteria. The concentrations varied from 50 to 0.1 μg/mL
(20.24 μM to 2.53 μM for Gad-1 and 23.04 μM to 2.88 μM for Gad-2).
Controls included buffer only andMH broth only. The plates were incu-
bated at 37 °C in a shaking incubator set at 140 RPM for 16 h. The MIC
was deﬁned as the lowest concentration of peptide that resulted in no
bacterial culture growth as judged by visual inspection of the opacity.
Each plate had duplicate rows and the plates were run in triplicate.
Assays were completed at pH 5 and pH 7.
2.3. Hemolytic assay
Fresh human red blood cells (RBCs) were washed three times in
150 mM NaCl + 20 mM Tris–HCl (Sigma-Aldrich Co) and resuspended
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5 × 108 RBC/mL. Two hundredmicroliters of RBC suspensionwas added
to 1.3 mL of peptide to give the appropriate ﬁnal concentration of pep-
tide as quoted in Table 1. The positive control (100% lysis) was 200 μL of
RBC suspension plus 1.3 mL of 1% Triton X-100 (Sigma-Aldrich) and the
negative control (0% lysis) was 200 μL of RBC suspension plus 1.3 mL of
PB. The solutionswere placed in a 37 °Cwater bath for an hour and cen-
trifuged at 850 g for 10 min at 4 °C. The supernatants were collected by
pipette, transferred to cuvettes and absorbance measured at 541 nm
using a Genesys 10S UV–VIS Thermo Scientiﬁc Spectrometer. Percent
hemolysis was calculated as:
Absorbance of sample–Absorbance of negative control
Absorbance of positive control
 
 100%
2.4. Cell culture and conditions
Murine Lewis lung carcinoma cells (LLC) and human prostate PC3
cancer cells were obtained from ATCC (Manassas, VA, USA). Human
ovarian HEY cancer cells were a kind gift fromDr.M. Nachtigal (Univer-
sity of Manitoba,Winnipeg, MB, Canada). LLC, PC3 and HEY cells were
maintained in a 37 °C incubator with a 10% CO2 humidiﬁed atmosphere
in DMEM culture medium (Sigma-Aldrich, Oakville, ON, Canada)
supplemented with 10% heat-inactivated fetal bovine serum (FBS),
100 U/mL penicillin, 100 μg/mL streptomycin, 2 mM L-glutamine, and
5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) at
pH 7.4 (all from Invitrogen, Burlington, ON, Canada), referred to as
cDMEM. LLC, PC3 and HEY were cultured in T75 tissue culture ﬂasks
(Sarstedt, QC, Canada) and were passaged as required, with cell conﬂu-
ence never exceeding 90%. U266 multiple myeloma cells were kindly
provided by Dr. Tony Reiman (Saint John Regional Hospital, Saint
John, NB, Canada). U266 cells were maintained at 37 °C in a 5% CO2 hu-
midiﬁed atmosphere in RPMI 1640 medium (Sigma-Aldrich Canada,
Oakville, ON, Canada) supplemented with 5% heat-inactivated FBS,
5mMHEPES (pH 7.4), 100 U/mL penicillin and 100 μg/mL streptomycin
(Invitrogen, Burlington, ON, Canada), referred to as cRPMI. Stock ﬂasks
were passaged as required to maintain optimal cell growth. All cells
were routinely shown to be free of mycoplasma contamination.
2.5. MTT viability assay
LLC, HEY, and PC3 cancer cells were seeded into 96-well ﬂat-bottom
plates (Thermo Scientiﬁc, Rochester, NY, USA) at 2 × 104 cells per well
and incubated overnight. Culture supernatants were then removed
and replaced with cDMEM adjusted to pH 6 or 7. Cells were then
cultured in the absence or presence of the indicated concentrations of
Gad-1 or Gad-2 for 24 h. At the end of culture, supernatants were re-
moved and replaced with fresh cDMEM, and thiazol blue tetrazolium
bromide (MTT; Sigma Aldrich, ON, Canada) was added to each well
(0.5mg/mL). The cells were incubated for 2 h to allow for the formation
of formazan crystals by mitochondrial dehydrogenases. Cells were cen-
trifuged for 5 min at 500 ×g and the supernatants removed. FormazanTable 1
Percent helicity of AMPs estimated from the ellipticity at 222 nm [35].
pH Gad-1 Gad-2
Buffer 5 7% 4%
20% TFE 5 16% 12%
20 mM SDS 5 25% 12%
POPC 5 37% 7%
POPC 6 35% 10%
POPC 7 42% 16%
POPG 5 56% 19%
POPG 6 79% 36%
POPG 7 100% 100%crystals were then solubilized with the addition of 100 μL of DMSO to
each well. The absorbance at 570 nm, as an indicator of live cells, was
measured using an ASYS Expert 96-well plate reader (Montreal Biotech
Inc., Dorval, QC, Canada). Cytotoxicity was calculatedwith the following
equation [1-(A570treatment / A570vehicle)]100, for each pH condition.
Each treatment condition was done in triplicate.
2.6. 7-AAD death assay
U266 cells were incubated in 24-well plates (5 × 105 cells per well)
for 1 h with vehicle, 50 μMGad-1 or Gad-2 at 37 °C in a 5% CO2 humid-
iﬁed atmosphere in RPMI-1640 + 0.5% FBS at pH 6 or 7. Cells were
stained with 7-AAD (eBioscience) 5 min before analysis by FACSCalibur
ﬂow cytometer (BD Biosciences, Mississauga, ON). The percentage of
dead cells were gated based on the live vehicle control cells.
2.7. Circular dichroism
The secondary structures of Gad-1 and Gad-2 were assessed in a
variety of environments using far-ultraviolet circular dichroism (CD)
spectroscopy [34]. To prepare the samples with lipids, lyophilized 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) or 1-palmitoyl-
2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (POPG) (Avanti Polar
Lipids Inc., Alabaster, Al) was dissolved in 20mMpH 5 dibasic phosphate
buffer to a concentration of 25mM, and subjected to ﬁve freeze-thaw cy-
cles. The resulting liposome solutions were extruded through a 200 nm
ﬁlter (Nuclepore Track-Etched Membranes, Whatman, Toronto ON)
under nitrogen gas pressure to make large unilamellar vesicles (LUVs).
Appropriate volumes of the LUV solutions were mixed with peptide
stock solution to give a ﬁnal lipid concentration of 1.4 mM and a ﬁnal
peptide concentration of 30 μM and the pH adjusted as necessary. CD
experiments were also performed with 30 μM peptide in buffer alone,
with 20 mM sodium dodecyl sulfate (SDS) micelles, and with 20%
triﬂuoroethanol (TFE). Spectra were collected (20 per analysis) in milli-
degrees using a Jasco J-810 spectropolarimeter (Jasco Inc., Easton, MD)
in the far ultraviolet range (190–260 nm) with a 0.5 mm quartz cuvette
at 25 °C. All sample preparations and CD spectra acquisitionswere repeat-
ed at least once— the spectra shown in Fig. 5 are representative scans.Pe
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Fig. 1.Minimal inhibitory concentration (MIC) for peptides to prevent growth of E. coli for
(A) Gad-1 at pH 5, (B) Gad-2 at pH 5, (C) Gad-1 at pH 7 and (D) Gad-2 at pH 7. Each bar
represents one of six replicate experiments and the length of the bars indicates the mini-
mum peptide concentration required to inhibit bacterial growth. No bar indicates an MIC
greater than 50 μg/mL (20.2 μM for Gad-1 and 23.0 μM for Gad-2).
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Fig. 2. Hemolytic activity of Gad-1 (square symbols) and Gad-2 (circles) after 1 h incuba-
tion time at 37 °C.
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converting the units to mean-residue ellipticity (MRE) according to
MRE= θ/(c × l × Nr), where θ is the recorded ellipticity, c is the peptide
concentration in dmol/L, l is the cell path-length in cm, and Nr is the
number of residues in the peptide. Percent helicity was estimated
from the normalized CD spectra based on the empirical formulae
given in [35], i.e. fH = (θ222 − θC)/(θH− θC), with θC = 2200− 53 T
and θH = (−44,000 + 250 T)(1− 3/Nr) where T is the temperature
in °C, fH is the fraction of helical structure, and θ222 is the MRE at
222 nm.Fig. 3. Effect of Gad-1 and Gad-2 on U266 multiple myeloma cell viability. Cells were treated w
panel) or 1 h (lower panel) and then stained with 7-AAD for 5 min before analysis by ﬂow cyto
determined by a one-way ANOVA with a Tukey–Kramer post-test.2.8. NMR experiments
Peptides (2 mM) were dissolved in buffers of 90/10% H2O/D2O (for
NOESY experiments) or 100% D2O (for TOCSY experiments) plus
150 mM deuterated sodium dodecyl sulfate (SDS) (Cambridge Isotope
Laboratories, Andover, MA) and 0.2 mM 4,4-dimethyl-4-silapentane-
1-sulfonic acid (DSS) as an internal reference, and adjusted to pH 5.
Samples were loaded into 5 mm thin-walled glass NMR tubes (Norell
Inc. Landisville, NJ). One-dimensional (1D) 1H and two-dimensional
(2D)NOESY and TOCSY spectra of the peptides in SDSmicelleswere ob-
tained using a Bruker Avance 600 MHz spectrometer equipped with a
TXI probe. For 1D 1H NMR, 16 scans were used. For 2D TOCSY experi-
ments, a DIPSI2 spin-lock sequence was used, with a mixing time of
80 ms, and 128 scans accumulated. For the 2D NOESY experiments, a
mixing time of 150 ms was used with 472 scans. All 2D experiments
had a recycle delay of 1 s. Spectra were processed using iNMR (http://
www.inmr.net) and analyzed with SPARKY [36].
2.9. Structure determination
Chemical shift assignments were assigned via standard methods
[37] using 2D TOCSY and NOESY data acquired in 90% H2O and 10%
D2O as well as 100% D2O at 35 °C, with help from the same experiments
at 40 °C and 45 °C in order to resolve ambiguities. NOEs were quantiﬁed
usingpeakheight from the 90/10%H2O/D2ONOESY spectra at 35 °C. The
NOEs were divided into three classes corresponding to strong, medium
and weak intensities and assigned target distances of 1.8–2.5 Å, 1.8–
3.5 Å and 1.8–5.0 Å respectively. In order to avoid overconstraining
the peptide structures, the calculations were carried out with some al-
terations to the “standard” NMR structure calculation methods forith vehicle control (V), 50 μMGad-1 or Gad-2 in cRPMI at pH 6 or pH 7 for 10 min (upper
metry. Data shown are the mean of at least 3 independent experiments ± SEM; *p b 0.05,
1455M. McDonald et al. / Biochimica et Biophysica Acta 1848 (2015) 1451–1461well-structured proteins. Speciﬁcally, hydrogen bond restraints were
not employed at all and helical dihedral angle restraints (φ=−60 ±
30° and ψ=−40 ± 40°) were only employed for residues with a HA
chemical shift index (CSI) b−0.25 ppm. The Gad-1 structure ensemble
was calculated using 217 unambiguous NOEs and 48 ambiguous NOEs.
The Gad-2 ensemble was calculated using 168 unambiguous NOEs and
77 ambiguous NOEs. Care was also taken to avoid overconstraining
the structures by retaining too many low energy conformers. To this
end only 20 structures of each peptide were calculated and the 7 lowest
energy structures, which in both cases were the complete set of struc-
ture calculations with no restraint violations, were retained. The struc-
tures were calculated using Xplor NIH [38] with the input ﬁles sa.inp,
anneal.inp and accept.inp.
3. Results
3.1. Functional studies with Gad-1 and Gad-2
Minimal inhibitory concentrations (MICs) for the peptides
against E. coli were measured at both pH 5 and pH 7 (Fig. 1). TheFig. 4. Cytotoxic effect of Gad-1 and Gad-2 on carcinoma cells. Lung (LLC), ovarian (HEY), and p
Gad-2 for 24 h at pH 6 or pH 7. Cell viability was then assessed by anMTT viability assay. Data
their respective pH conditions, of at least 4 independent experiments. Statistical signiﬁcance
***p b 0.001.activity of Gad-1 does not appear to be very pH dependent, as an
MIC of 5.1 μM(12.5 μg/mL) was determined in 4 out of 6 repeated ex-
periments at pH 5, and in 5 out of 6 experiments at pH 7. Gad-2 however,
exhibited greater activity at pH 5 than at pH 7, with an MIC of 11.5 μM
(25 μg/mL) in 4 out of 6 experiments at pH 5, but N 23.0 μM (50 μg/mL)
in 4 out of 6 experiments at neutral pH. This is interesting considering
that Gad-1 has ﬁve histidine residues and Gad-2 only four. At both pHs,
Gad-1 was more active than Gad-2.
Hemolysis assays were performed to measure the activity of Gad-1
and Gad-2 against human RBCs (Fig. 2). The HC50, i.e. the peptide con-
centration that causes 50% lysis of RBCs, was 43 μM for Gad-1 and
56 μM for Gad-2. Since there is a minimal amount of RBC lysis at the
MIC values of the peptide, it appears that Gad-1 and Gad-2 are selective
in their activity against bacteria.
Further studies were performed to examine Gad-1 and Gad-2 killing
ofmultiplemyeloma cells at acidic and neutral pH (Fig. 3). Similar to the
E. coliMIC experiments, Gad-1wasmore active than Gad-2 at both pHs,
but Gad-2 wasmore sensitive to pH than Gad-1. A 50 μM concentration
of Gad-1 killed 92% of the cells at pH 7 after 10min incubation and there
was no signiﬁcant difference in cell killing at pH 6. Gad-2 killed 22% ofrostate (PC3) carcinoma lines were treated with the indicated concentrations of Gad-1 or
are shown as the mean percent cytotoxicity (± SE), relative to vehicle-treated cells under
was determined by two-way ANOVA with a Bonferroni post-test. *p b 0.05, **p b 0.01,
1456 M. McDonald et al. / Biochimica et Biophysica Acta 1848 (2015) 1451–1461the cells at pH 7 and there was a statistically signiﬁcant difference at
pH 6, with 49% of the cells killed. Similar results were obtained with a
one hour incubation time. Gad-1 is substantially more active in the
multiple myeleoma cell assays than it is in the human red blood cell
assays; however, for Gad-2 the results are more comparable — at
pH 7, Gad-2 appears to have similar activity against RBCs and multiple
myeloma cells.
The anti-cancer properties of Gad-1 and Gad-2 against a range of
carcinomas, under acidic and neutral pH conditions, were also investi-
gated (Fig. 4). Both Gad-1 and Gad-2 demonstrated concentration-
dependent cytotoxicity against LLC cells, HEY ovarian cancer cells, and
PC3 prostate cancer cells. Consistent with the other functional studies,
Gad-1 showed a greater cytotoxic effect compared to Gad-2. In contrast
to the pH dependence of the results with E. coli and multiple myeloma
cells, both peptides exhibited signiﬁcantly greater killing of ovarian
and prostate cells under acidic conditions (two-way ANOVA, p b 0.05),
while Gad-2 showed a signiﬁcant pH-dependent alteration in activity
with all three carcinoma cell lines. The pH-dependent effect was more
pronounced with Gad-2 than Gad-1 in LLC and ovarian cancer cells in
which peptide-mediated killing at 50 μM was increased by approxi-
mately four-fold under acidic conditions.3.2. Secondary structure dependence on environment
Circular dichroism experiments were performed with Gad-1 and
Gad-2 in order to elucidate their conformational preferences in a variety
of environments and pHs (Fig. 5). Percent helicity was also estimated
from the ellipticity value at 222 nm [35] (Table 1). In zwitterionic
LUVs composed of POPC, the degree of helicity is similar at pH 5, 6,
and 7 and is on average 38% for Gad-1 and 11% for Gad-2. On the
other hand, in anionic POPG LUVs, the helicity is strongly dependent
on pH with % helicity for Gad-1 running from 56% at pH 5 to 100% at
pH 7 and for Gad-2 running from 19% at pH 5 to 100% at pH 7. As
LUVs are not suitable for high resolution, solution NMR structural
work, comparisons were also made to solution NMR compatibleGad-1
Gad-1
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Fig. 5. Far-UV CD spectra of Gsolvents including 20% TFE and SDS micelles at pH 5. SDS micelles
were chosen for high resolution structure determination of the Gad
peptides as this environment induces an intermediate level of peptide
structuring.3.3. NMR structure determination
Solution NMR data was collected for Gad-1 and Gad-2 in 150 mM
SDS micelles at pH 5. Chemical shift assignments employed 2D-NOESY
and 2D-TOCSY data acquired at 35 °C, with help from data at 40 and
45 °C to resolve overlap. All of the expected resonances could be
assigned, with the exception of Gad-1 Phe1. Notably, HD2 (C2) reso-
nances were observed for all histidine residues in Gad-1 and Gad-2,
conﬁrming that all the histidines are indeed in their protonated form
under these conditions [39].
Secondary structure indicators, including chemical shift index (CSI)
and NOE patterns are summarized in Fig. 6. More negative CSI values
for Gad-1 compared to Gad-2 indicate a greater helical propensity for
Gad-1. A greater overall helicity for Gad-1 is also supported by greater
numbers of NOEs between residues spaced 3 and 4 residues apart, as
well as the higher number of strong sequential HN–HN NOEs observed
for Gad-1 compared to Gad-2 — which are indicative of helical
structure [37].
Structure calculations were carried out based on 265 inter-residue
NOEs for Gad-1 and 245 inter-residues NOEs for Gad-2. Particular care
was taken to calculate structure ensembles with the largest variety of
structures consistent with the experimental data — to avoid over-
constraining the structures. While typical NMR structure calculations
normally employ both dihedral and hydrogen bond restraints, for
Gad-1 and Gad-2 we did not employ any hydrogen bond restraints
and added helical dihedral angle restraints only for residues with
CSI b−0.25 ppm (Fig. 6).
The resulting structure ensemble for Gad-1 is well ordered over the
C-terminal 17 residues (backbone RMSD for residues 5–21 = 0.39 Å)
and more structurally heterogeneous for the N-terminal 4 residuesngth (nm)
Gad-2
Gad-2
ad-1 and Gad-2 at 25 °C.
dNN(i,i+1) 
d N(i,i+1) 
d N(i,i+1) 
dNN(i,i+2) 
d N(i,i+3) 
d (i,i+3) 
d N(i,i+4) 
dNN(i,i+1) 
d N(i,i+1) 
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CSI 
-0.5 
0 
Gad-1 
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Fig. 6. Secondary structure indicators for Gad-1 and Gad-2 in SDS micelles at 35 °C. The upper panels display chemical shift index (CSI). Lower panels indicate NOEs. The interaction
strengths for theHNi−HNi + 1 and HAi−HNi + 1 NOEs are indicated by the height of the bars as strong,mediumorweak. All other interactions are indicated by their presence or absence.
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9 and residues 12 to 20 (Fig. 7B). For the most homogeneously struc-
tured part of the peptide, i.e. residues 5 to 21, there is well-deﬁned
partitioning of hydrophobic sidechains to one side of the peptide and
hydrophilic sidechains to the opposite face (Fig. 7C). The tryptophan
residue, which is itself amphipathic and potentially quite important
for function [40], locates to the interface between the polar and
non-polar faces of the peptide. The break in the helix occurs at Serine
10/Histidine 11.
As expected from the circular dichroism data, the ensemble of calcu-
lated structures for Gad-2 ismuchmore disordered than for Gad-1, with
a backbone RMSD of 1.5 Å for residues 5 to 19 (Fig. 8). Like Gad-1, Gad-2
is also most structurally heterogeneous in the N-terminal 4 residues.
Even though all 7 lowest energy structures calculated for Gad-2 were
consistent with the experimentally determined NMR data, the struc-
tures display a variety of secondary structures (with helical regions col-
ored magenta in Fig. 8A). Residues 9–12 appear to have the strongest
helical tendency —with helical structure in 5 out of 7 calculated struc-
tures. Residues 6–8 and 15–17 displayed weaker helical tendency
with helical structure in 3 out of 7 and 2 out of 7 calculated structures,
respectively. Thus, the central helical region tends to break at Glycine
13/Serine 14.
The Gad-1 and Gad-2 NMR data were examined for indications that
the peptides might be forming dimers. However, no likely inter-peptide
NOEs could be identiﬁed and comparison of 1D NMR spectra of samples
with varying peptide concentration revealed no signs of oligomerization.
4. Discussion
By revealing structure-function relationships in Gad-1 and Gad-2,
we are hoping to contribute knowledge about factors that inﬂuence
the speciﬁcity of AMPs and thus to contribute to rational optimization
of AMP sequences to improve their therapeutic ratios. Functionalstudies of Gad-1 and Gad-2 reveal that while Gad-1 has more activity
than Gad-2 at all pH values tested, Gad-2's anti-E. coli activity is much
more pH-dependent than Gad-1's (Fig. 1). Similarly, against the multi-
ple myeloma and three carcinoma cell lines assayed, Gad-1 is always
more active than Gad-2, regardless of pH. Interestingly, while Gad-2's
activity was signiﬁcantly pH-dependent in all four cancer cell lines,
Gad-1 was also pH dependent in two of these, although the fold-
change was not as much as for Gad-2 (Figs. 3 and 4). In exploring the
mechanisms for Gad-2's strong pH sensitivity compared to Gad-1's
mild pH sensitivity, we need to consider factors such as peptide struc-
ture, as well as both the hydrophobic and electrostatic components of
peptide–lipid interactions.
Circular dichroism experiments allow us to compare the helicity of
the peptides in a variety of lipid and other environments (Fig. 5). Lipid
vesicles composed of POPC LUVs provide a crude mimic of non-
cancerous eukaryotic cell membranes, which are composed largely of
zwitterionic lipids. On the other hand, vesicles composed of the anionic
lipid, POPG, reﬂect the character of the more negatively charged nature
of the headgroups in many bacterial or cancer cell membranes [11],
although only to a ﬁrst approximation as bacterial membranes are typ-
ically composed largely of phosphatidylethanolamine and cardiolipin in
addition to the PG, and also have a lipopolysaccharide (LPS) layer that is
likely important for AMP interactions [41]. In zwitterionic POPC, there is
little pH dependence of Gad-1 or Gad-2 helicity and the overall level of
helical structuring is much lower than in POPG at any pH (Table 1). This
indicates that the more robust electrostatic interactions between the
peptides and the anionic PG headgroups compared to with the PC
headgroups, have a strong inﬂuence on peptide structure.
Comparing the helicity of the peptides at pH 7, i.e., when the histi-
dine sidechains are expected to be deprotonated, in POPG versus POPC
reveals aspects of peptide–lipid interactions. Both peptides are 100% he-
lical in POPG, but in POPC exhibit much less helicity; 42% for Gad-1 and
16% for Gad-2. This is in contrast to what we have observed before for
AB
C
Fig. 7. 3D structure of Gad-1 with the helical portion of the backbone colored magenta, hydrophobic sidechains yellow, histidines orange, serine green and arginine blue. (A) Ensemble
consisting of 7 individual structures that are consistent with the experimental data. (B) Representative structure with the histidines labeled. (C) Representative structure rotated by
90° to show the amphipathicity.
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and zwitterionic environments [42] and to the related peptide piscidin's
observed behavior in structuring strongly helical in a zwitterionic envi-
ronment [43]. On the other hand, similar to the Gads, LL37 has been ob-
served to be random in POPC, but helical in a mix of POPC and POPG
[44]. The major alteration in structure with lipid environment for the
Gad peptides implies that charge interactions between PG and non-
histidine-sidechain moieties on the peptide have a strong inﬂuence on
peptide structure. The charged groups on Gad-1 at pH 7 would be the
positively charged N-terminus and Arg-14 and Arg-18 sidechains.
When completely helical, Gad-1 can form a perfectly helical structure
with the N-terminus near the polar/apolar interface, and the arginines
at the polar interface apparently forming helix-stabilizing interactions
with the PG headgroups (Fig. 9). That much of the helical structure islost in POPC indicates the importance to helix stabilization of the Arg/
N-terminus interactions with PG.
With Gad-2 at pH 7, the charged moieties consist of the N-terminus,
Arg-19, plus the negatively charged side chain of Asp-18, and thus both
electrostatic attraction and repulsion come into play. The almost com-
plete loss of helical structure upon switching from POPG into POPC indi-
cates that interactions with the PG headgroups are key in inducing the
helical structure. This behavior may relate to the disposition of the
charged peptide groups. That is, the positively charged groups at the
N-terminus and the Arg-19 sidechain locate to opposite ends of the
polar/apolar interface of the peptide. However, the negatively charged
Asp-18 locates near the center of the polar face where it would be re-
pelled by the PG headgroups, but could have favorable interactions
with PC headgroups (Fig. 9).
AB
Fig. 8. 3D structure of Gad-2 with the helical portion of the backbone colored magenta, hydrophobic sidechains yellow, histidines orange, serine green, arginine blue and aspartate red.
(A) Ensemble consisting of 7 individual structures that are consistent with the experimental data. Sidechains are omitted for clarity. (B) Representative structure with the histidines
labeled.
1459M. McDonald et al. / Biochimica et Biophysica Acta 1848 (2015) 1451–1461Next, we turn to the experiments at acidic pH, which reveal the role
of the positive charge on the histidines. In POPC, dropping the pH from7
to 6 or 5 has very little effect on helicity. That is to say, the partial helical
structuring observed in POPC (~38% for Gad-1 and ~11% for Gad-2) is
largely unaffected by histidine charge— presumably because of the ab-
sence of strong electrostatic interactions with the PC headgroups. On
the other hand, in anionic lipid, i.e. POPG LUVs, pH has a dramatic effect
on the helicity of both peptides. While both peptides are 100% helical at
pH 7, the helicity decreases dramatically as the pH is reduced — with
Gad-1's helicity dropping to 56% at pH 5 and Gad-2's helicity droppingGad-1
Fig. 9. Helical wheel plots [47] of Gad-1 and Gad-2 indicate well-to 19% at pH 5. Gad-2's greater sensitivity of helicity to pH is in keeping
with the greater sensitivity of its activity to pH.
It is notable that this decrease in Gad-2 helicitywith reduced pH cor-
responds to an increase in activity. AMPs are frequently assumed to ex-
hibit the opposite structure–function relationship— i.e. to becomemore
active when they assume a helical structure, although this observation
is far from universal. On the other hand, the general rule of “more
helicity equals more activity” does seem to hold true when comparing
Gad-1 to Gad-2 — Gad-1 is more functionally active than Gad-2 and
also exhibits greater helicity in all the conditions tested. Therefore,Gad-2
deﬁned amphipathicity when the peptides are 100% helical.
1460 M. McDonald et al. / Biochimica et Biophysica Acta 1848 (2015) 1451–1461there appears to be no simple rule for correlating helicity with antimi-
crobial activity, at least for the Gad peptides.
Since the structure of Gad-1 and Gad-2 depend very much on the
composition of their lipid environment, the high resolution structures
determined (Figs. 7,8) are best viewed as “base” structures that indicate
the structural tendencies under conditions where an intermediate level
of helicity is present. In both peptides, the central and C-terminal re-
gions show the strongest tendency to structure as an amphipathic
helix, whereas the N-terminal regions are the most disordered and do
not exhibit partitioning of the hydrophobic and polar residues. Such
“imperfect amphipathicity” has been suggested to be important to dis-
ruption of membranes by AMPs [45]. For Gad-2, which demonstrates
extreme sensitivity of its structure and activity with histidine charge,
it may be that the “imperfect amphipathicity” induced by lowering the
pH and hence disrupting the anionic-lipid bound structure, is critical
to achieving the right balance of amphipathicity with imperfection in
order to maximize the activity. As to why Gad-2 is more sensitive to
pH than Gad-1 even though Gad-1 has ﬁve histidine residues to Gad-
2's four, we suggest the answer lies with the overall charge balance of
the two peptides, which is quite different at neutral pH. Gad-1 carries
a charge of +3 at pH 7 and +8 at pH 5, whereas Gad-2 has a charge
of only +1 at neutral pH and +5 at pH 5. Consistent with this sugges-
tion, Kharidia et al. have observed pH-dependent MICs only in the
least positively charged members of two different histidine-containing
peptide families [22]. In addition to the role of histidine's positive charge
in altering the lipid-peptide interactions of the Gads discussed above,
our earlier simulation studies indicated a special role for sequential
pairs of histidines [46]. In the simulations, sequential pairs of histidines,
but not single histidines, display a strong preference to closely associate
with bilayer pores, and this preference persists even if the histidines are
uncharged. Thus Gad-2, with its two pairs of histidines, compared to
Gad-1, with only one histidine pair, may be poised close to a threshold
for membrane disruption; only a small change in electrostatic interac-
tions (e.g. histidine protonation and/or increase in anionic lipid constit-
uents) is required to activate antimicrobial activity.
In summary, our work demonstrates a higher level of pH depen-
dence of bacterial growth inhibition and cancer cell killing for the
AMP Gad-2 in comparison to Gad-1, both histidine-rich peptides.
When considering themechanism for this functional tuning, it is impor-
tant to keep in mind that while lipid-AMP interactions are central in
AMP function,modelmembrane studies such as this one do not address
potentially important interactionswith other cell envelope components
including lipopolysaccharide and peptidoglycan. None-the-less, the
greater functional plasticity observed for Gad-2 correlateswith a greater
structural plasticity. While both Gad-1 and Gad-2 demonstrated differ-
ent levels of helicity depending on pH and lipid environment, Gad-2
shows much more drastic structural changes. Interestingly, the pH
with the highest level of Gad-2 functional activity does not correspond
to the pH with the greatest helicity, indicating that the most functional
conformation of Gad-2 is not necessarily the most helical, perfectly am-
phipathic structure.We propose instead that a balance between amphi-
pathic and mixed hydrophobic/hydrophilic structural features are
needed for maximal activity. Other factors that may inﬂuence Gad-2's
more ﬁnely tuned structure-functional relationships include that its
histidines appear in pairs, rather than singly, as well as Gad-2's lower
overall positive charge at pH 7. Thus, this examination of the Gad pep-
tides, alongwith our earlier simulation study [46], suggest that in trying
to improve the therapeutic ratio of other AMPs in development, consid-
eration should be given to including histidine-pairs, keeping the overall
charge of the peptide modest, and retaining a degree of structural
plasticity and imperfect amphipathicity.
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